Table 1: Levels of resistance among nonnucleoside reverse transcriptase inhibitors, nucleoside reverse transcriptase inhibitors and protease inhibitors in 66 treatment-naïve (no; not exposed to treatment) and 43 treatment-experienced patients (yes; exposed to treatment)